NewMed Energy announced the successful completion of the institutional phase of an offering of a new bond series (Series B).

During the institutional tender, enormous demand was recorded from the market's leading institutional investors, totaling about NIS 2.4 billion. Of the total demand, the partnership decided to accept orders totaling about NIS 1.751 billion.
Terms of the Series and Fundraising Objectives
The new bond series is expected to be listed for trading on the Tel Aviv Stock Exchange (TASE). It will bear annual interest of up to 4.54%, without indexation or collateral. The series has an average duration of about 5 years, with repayments in installments spread from 2027 through 2034. The partnership intends to obtain approval from rating agency Midroog for an A1 rating for the full amount of the series.

The offering proceeds are intended to diversify the partnership's financing sources and support the implementation of its ambitious work plans for the coming years. Key objectives include developing Phase B of the Leviathan reservoir, advancing the development of the Aphrodite reservoir, which is approaching a final investment decision, and repaying existing debt. Completion of the entire fundraising is subject to publication of the public tender and receipt of the required approvals.
Fundraising Leadership and Advisers
The fundraising was led by the partnership's management, headed by CEO Niv Sarna and Deputy CEO and CFO Tzachi Havusha.

The offering was conducted in cooperation with underwriters Barak Leumi Underwriting, Discount Underwriting and Leader Underwriters. The offering process was accompanied by the law firm Agmon with Tulchinsky and financial adviser Shay Adler.
Partnership Management: "A Clear Expression of Confidence in Financial Strength"
NewMed Energy CEO Niv Sarna said the results of the institutional tender indicate a clear expression of confidence by institutional investors in the partnership and its business strategy.
According to Sarna, the offering proceeds, combined with the strong cash flow from the Leviathan reservoir, will enable the partnership to continue advancing its development plans for the coming years, including developing Phase B of Leviathan and the Aphrodite reservoir, while providing returns to investors and maintaining an appropriate leverage level.

Deputy CEO and CFO Tzachi Havusha added that the successful fundraising and high demand reflect the capital market's confidence in the partnership's financial strength and execution capabilities. Havusha stressed that the fundraising strengthens financial flexibility and creates an efficient and balanced capital and debt structure, which will enable the partnership to generate value for investors over time.









